Clinical trials
Active, not recruiting Metabolic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 12 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| KK Women's and Children's Hospital | 3 |
| AdventHealth Translational Research Institute | 2 |
| Agios Pharmaceuticals, Inc. | 2 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 2 |
| 4D Molecular Therapeutics | 1 |
| AO GENERIUM | 1 |
| Anne-Sophie Brazeau | 1 |
| Auburn University | 1 |
| Diamyd Medical AB | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 42 |
| Obesity | 14 |
| Glucose Metabolism Disorders | 10 |
| Diabetes Mellitus, Type 2 | 9 |
| Endocrine System Diseases | 8 |
| Diabetes Mellitus | 6 |
| Genetic Diseases, Inborn | 5 |
| Nervous System Diseases | 4 |
| Brain Diseases, Metabolic | 3 |
| Cardiovascular Diseases | 3 |
Trials
Showing 26 to 42 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.